Fig. 9.
Mutant c-jun–containing 8226 cells have a blunted TRE-CAT response to anti-fas and dexamethasone.Neo control or dominant negative c-jun–transduced 8226 cells were transfected with TRE-CAT and treated without or with anti-fas (0.5 μg/mL) or dexamethasone (10−6mol/L) for 10 minutes. TRE-CAT activity is mean ± SE of three separate experiments.